Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on June 12, 2025
AIM ImmunoTech Announces NYSE American Removal of Trading Suspension
GlobeNewswire
·
June 12, 2025
OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (OTC Pink: AIMID) (NYSE American: AIM) (“AIM” or the “Company”) today announced that the staff of NYSE Regulation has withdrawn its delisting determination and will be lifting the trading …
Nectero Medical Secures Category III CPT Codes for Investigational Therapy to Treat Small- to Medium-Sized AAAs
GlobeNewswire
·
June 12, 2025
TEMPE, Az., June 12, 2025 (GLOBE NEWSWIRE) -- Nectero Medical, a clinical-stage biotechnology company developing therapies for aneurysmal disease, announced today that the American Medical Association’s CPT Editorial Panel has approved two Category III CPT …
DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario
GlobeNewswire
·
June 12, 2025
TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("”DiagnaMed” or “DMED") (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John …
Rgenta Therapeutics Presents Preclinical Data from Lead Program, RGT-61159, a Potent and Selective Small Molecule Inhibitor of MYB RNA, Supporting its Application in the Treatment of Acute Myeloid Leukemia (AML)
GlobeNewswire
·
June 12, 2025
WOBURN, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, …
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
GlobeNewswire
·
June 12, 2025
Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third …
Aayush Wellness Bridging Ancient Ayurvedic Wisdom with Modern Wellness offering Aayush Herbal Masala – A Natural Alternative
GlobeNewswire
·
June 12, 2025
NEW DELHI, India, June 12, 2025 (GLOBE NEWSWIRE) -- Aayush Wellness Limited, a trailblazer in India's preventive healthcare sector, seamlessly integrates the time-honored principles of Ayurveda with contemporary scientific advancements. Their product line …
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics
GlobeNewswire
·
June 12, 2025
Ra’anana, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a biotechnology company developing intranasal drug delivery systems, today announced encouraging preclinical results from a recent study …
Angitia Biopharmaceuticals Announces Topline Results from First in Human Study of AGA2115, A Bispecific Antibody for the Treatment of Osteogenesis Imperfecta
GlobeNewswire
·
June 12, 2025
WESTLAKE VILLAGE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced topline …
Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
GlobeNewswire
·
June 12, 2025
Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional durability data from Phase 1b study of DISC-0974 in anemia of …
Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
GlobeNewswire
·
June 12, 2025
– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – 93% (41/44) and 89% (24/27) CRc observed in NPM1-m and …
NewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate Market
GlobeNewswire
·
June 12, 2025
The Company’s initial investment into the Emirate of Ras Al Khaimah comes ahead of major tourism and infrastructure developments NewGen plans to diversify via additional real estate investments in Abu Dhabi pending potential transactions to provide …
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
GlobeNewswire
·
June 12, 2025
CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received the remaining $10 million in …
Spring Bio Solution führt NCE Grid zur Entschlüsselung von Paragraph-IV-Anmeldungen und First-to-File-Möglichkeiten ein
GlobeNewswire
·
June 12, 2025
SOMERSET, New Jersey, June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, ein weltweit führender Anbieter von Vergleichsprodukten und Zubehör für klinische Studien, hat NCE Grid eingeführt – die weltweit erste kostenlose NCE-1-Informationsplattform, die …
Spring Bio Solution lance NCE Grid pour décoder les dépôts Para IV et les opportunités de premier déposant
GlobeNewswire
·
June 12, 2025
SOMERSET, New Jersey, 12 juin 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, l’un des leaders mondiaux de l’approvisionnement en comparateurs et en matériel pour essais cliniques, a lancé NCE Grid, une plateforme d’informations NCE-1 gratuite. Conçue pour …
Spring Bio Solution Meluncurkan NCE Grid untuk Mendekode Peluang Pengajuan Para IV dan First-to-File
GlobeNewswire
·
June 12, 2025
SOMERSET, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, pemimpin global dalam pengadaan obat pembanding dan perlengkapan uji klinis, telah meluncurkan NCE Grid, platform kecerdasan NCE-1 gratis pertama di dunia - yang dibuat untuk mendekode, …
スプリング・バイオ・ソリューション (Spring Bio Solution) 、パラグラフIV証明書を伴う申請 (Para IV Filing) およびファースト・トゥ・ファイル機会を解析するNCEグリッド (NCE Grid) を発表
GlobeNewswire
·
June 12, 2025
ニュージャージー州サマセット発, June 12, 2025 (GLOBE NEWSWIRE) -- コンパレータ調達および治験薬供給のグローバルリーダーであるスプリング・バイオ・ソリューションは、世界初の無料NCE-1インテリジェンス・プラットフォームであり、パラグラフIVおよびNCE-1の機会をリアルタイムで解析・集約・可視化することを目的として構築されたNCEグリッドを発表した。 これまで、NCE独占期間の満了およびパラグラフIV …
Spring Bio Solution, 패러그래프 IV 준비와 최초 출원 가능성 해석해주는 NCE Grid 플랫폼 선보여
GlobeNewswire
·
June 12, 2025
미국 뉴저지주 서머싯, June 12, 2025 (GLOBE NEWSWIRE) -- 대조약 공급 및 임상시험 용품 분야의 글로벌 선도 기업 Spring Bio Solution이 세계 최초로 무료 NCE-1 인텔리전스 플랫폼 NCE Grid를 선보였다. 이 플랫폼은 패러그래프 IV 준비와 NCE-1 가능성을 실시간으로 해석하고, 중앙화 및 시각화하기 위해 설계되었다. 지금까지 NCE 독점권 만료일 추적과 패러그래프 IV 증명서 제출은 중앙화된 솔루션이 없어 …
Spring Bio Solution Melancarkan NCE Grid untuk Menyahkod Pemfailan Para IV dan Peluang Pemfail Pertama
GlobeNewswire
·
June 12, 2025
SOMERSET, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, peneraju global dalam penyumberan komparator dan bekalan percubaan klinikal telah melancarkan NCE Grid, platform risikan NCE-1 percuma pertama di dunia—dibangunkan untuk menyahkod, …
Spring Bio Solution 推出 NCE Grid，用于分析 Para IV 申请和“首先申请”机会
GlobeNewswire
·
June 12, 2025
萨默塞特，新泽西州, June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution 是对照药采购和临床试验用品领域的全球领导者，近日推出了 NCE Grid，这是全球首个免费的 NCE-1（新化学实体批准日期满48个月后的第一天，通常被称为“首仿日”）情报平台，用于实时分析及实现 Para IV（第IV段声明专利挑战） 和 NCE-1 机会的集中化和可视化。 在这之前，追踪 NCE 独占期到期情况和 Para IV …
Spring Bio Solution เปิดตัว NCE Grid เพื่อถอดรหัสการยื่นเอกสาร Para IV และโอกาสในการยื่นคำขอครั้งแรก
GlobeNewswire
·
June 12, 2025
ซอเมอร์เซ็ต นิวเจอร์ซีย์, June 12, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution ผู้นำระดับโลกในด้านการจัดหาตัวเปรียบเทียบและอุปกรณ์การทดลองทางคลินิก ได้เปิดตัว NCE Grid แพลตฟอร์มปัญญาประดิษฐ์ NCE-1 ฟรีแห่งแรกของโลกที่สร้างขึ้นเพื่อถอดรหัส การรวมข้อมูล …